Latest Breaking News On - Jianzhong zhang - Page 1 : vimarsana.com

Chinese GPU Maker Moore Threads Lays Off Workers, Restructures After US Sanctions

Moore Threads was sanctioned by the U.S. government last month, and the layoffs are a direct response.

United statesJianzhong zhangAi strategy groupMetaverse computing strategy groupMoore threadsChina general managerMetaverse computing strategy

LNK01001 Achieves Primary End Point in Phase II Trial for Atopic Dermatitis

Patients given LNK01001 showed significant improvement in Eczema Area and Severity Index scores over placebo.

Jianzhong zhangLynk pharmaceuticals co ltdDermatology division of the chinese medical associationDermatology department at peking university people hospitalEczema areaSeverity indexGlobal assessmentDermatology divisionChinese medical associationDermatology departmentPeking university peopleCommon terminology criteria

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Jianzhong zhangHenry wuLynk pharmaceuticals co ltdLynk pharmaceuticalsDermatology division of the chinese medical associationDermatology department at peking university people hospitalLynk pharmaceuticalsProfessor jianzhongDermatology departmentPeking university peopleGlobal assessmentDermatology divisionChinese medical associationChief development officer

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

United statesKintor pharmaJianzhong zhangPrnewswire kintor pharmaceutical limited pharmaKintor pharmaceuticalUniversity people hospitalChina national medical products administrationPharmaceutical limitedLong term safety trialProfessor jianzhong zhangPeking university peopleLong term safety

Crisaborole Ointment Found to be Effective for Atopic Dermatitis in Younger Patients from China, Japan

New phase 3 data on patients with eczema in China and Japan showed that crisaborole, 2%, was efficacious and safe in patients aged 2 and older, lining up with data from studies done in Western countries.

Ann dermatolJianzhong zhangUniversity people hospitalPeking university peopleEczema areaSeverity indexPeak pruritus numerical rating scale